These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28903494)

  • 21. Multiple exposures to sarin vapor result in parasympathetic dysfunction in the eye but not the heart.
    Dabisch PA; To F; Kerut EK; Horsmon MS; Mioduszewski RJ
    Toxicol Sci; 2007 Sep; 99(1):354-61. PubMed ID: 17578861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The oxime pro-2-PAM provides minimal protection against the CNS effects of the nerve agents sarin, cyclosarin, and VX in guinea pigs.
    Shih TM; Guarisco JA; Myers TM; Kan RK; McDonough JH
    Toxicol Mech Methods; 2011 Jan; 21(1):53-62. PubMed ID: 21117832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple actions of anticholinesterase agents on chemosensitive synapses: molecular basis for prophylaxis and treatment of organophosphate poisoning.
    Albuquerque EX; Deshpande SS; Kawabuchi M; Aracava Y; Idriss M; Rickett DL; Boyne AF
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S182-203. PubMed ID: 2868960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time dependent dual effect of anti-inflammatory treatments on sarin-induced brain inflammation: Suggested role of prostaglandins.
    Chapman S; Grauer E; Gez R; Egoz I; Lazar S
    Neurotoxicology; 2019 Sep; 74():19-27. PubMed ID: 31095963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of cholinergic and neuromuscular toxicity following acute exposure to sarin and VX in rat.
    Gupta RC; Patterson GT; Dettbarn WD
    Fundam Appl Toxicol; 1991 Apr; 16(3):449-58. PubMed ID: 1855618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. In vitro and in vivo quantitative characterization.
    Raveh L; Grunwald J; Marcus D; Papier Y; Cohen E; Ashani Y
    Biochem Pharmacol; 1993 Jun; 45(12):2465-74. PubMed ID: 8328984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural Detoxification Capacity to Inactivate Nerve Agents Sarin and VX in the Rat Blood.
    Bajgar J; Cabal J; Kassa J; Pavlík M
    Acta Medica (Hradec Kralove); 2015; 58(4):128-30. PubMed ID: 26960825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel brain-penetrating oximes for reactivation of cholinesterase inhibited by sarin and VX surrogates.
    Chambers JE; Meek EC; Chambers HW
    Ann N Y Acad Sci; 2016 Jun; 1374(1):52-8. PubMed ID: 27153507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The benefit of combination of oximes for the neuroprotective efficacy of antidotal treatment of sarin-poisoned rats.
    Kassa J; Kunesova G
    Toxicol Mech Methods; 2012 May; 22(4):260-7. PubMed ID: 22149934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic efficacy of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) against organophosphate intoxication.
    Bueters TJ; Groen B; Danhof M; IJzerman AP; Van Helden HP
    Arch Toxicol; 2002 Nov; 76(11):650-6. PubMed ID: 12415428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central neuroprotection demonstrated by novel oxime countermeasures to nerve agent surrogates.
    Chambers JE; Meek EC
    Ann N Y Acad Sci; 2020 Nov; 1479(1):5-12. PubMed ID: 32319115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-level exposure of guinea pigs and marmosets to sarin vapour in air: lowest-observable-adverse-effect level (LOAEL) for miosis.
    van Helden HP; Trap HC; Kuijpers WC; Oostdijk JP; Benschop HP; Langenberg JP
    J Appl Toxicol; 2004; 24(1):59-68. PubMed ID: 14745848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supralethal poisoning by any of the classical nerve agents is effectively counteracted by procyclidine regimens in rats.
    Myhrer T; Mariussen E; Enger S; Aas P
    Neurotoxicology; 2015 Sep; 50():142-8. PubMed ID: 26318504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impairment of spatial memory following low-level sarin inhalation exposure and antidotal treatment in rats.
    Kassa J; Krejcová G; Vachek J
    Acta Medica (Hradec Kralove); 2002; 45(4):149-53. PubMed ID: 12587782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determining a threshold sub-acute dose leading to minimal physiological alterations following prolonged exposure to the nerve agent VX in rats.
    Bloch-Shilderman E; Rabinovitz I; Egoz I; Yacov G; Allon N; Nili U
    Arch Toxicol; 2018 Feb; 92(2):873-892. PubMed ID: 29127449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The VR, the Russian version of the nerve agent VX].
    Cuquel AC; Dorandeu F; Ceppa F; Renard C; Burnat P
    Ann Pharm Fr; 2015 May; 73(3):180-9. PubMed ID: 25592653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity Based Protein Profiling Leads to Identification of Novel Protein Targets for Nerve Agent VX.
    Carmany D; Walz AJ; Hsu FL; Benton B; Burnett D; Gibbons J; Noort D; Glaros T; Sekowski JW
    Chem Res Toxicol; 2017 Apr; 30(4):1076-1084. PubMed ID: 28267914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intramuscular ophthalmic homatropine vs. atropine to prevent lethality in rates with dichlorvos poisoning.
    Bryant SM; Wills BK; Rhee JW; Aks SE; Maloney G
    J Med Toxicol; 2006 Dec; 2(4):156-9. PubMed ID: 18072136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of LCt(50)s in anesthetized rats exposed to aerosolized nerve agents.
    Collins JL; Peng X; Lee R; Witriol A; Pierre Z; Sciuto AM
    Toxicol Mech Methods; 2013 Feb; 23(2):127-33. PubMed ID: 22978758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of miosis threshold from whole-body vapor exposure to sarin in African green monkeys.
    Genovese RF; Benton BJ; Oubre JL; Fleming PJ; Jakubowski EM; Mioduszewski RJ
    Toxicology; 2008 Feb; 244(2-3):123-32. PubMed ID: 18096290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.